PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33374216-0	2020	Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden.	Idarubicin	38-48	nucleophosmin 1	Homo sapiens	124-128	
20172040-0	2010	Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.	Idarubicin	168-178	nucleophosmin 1	Homo sapiens	71-84	
20172040-2	2010	In this study we describe treatment results from a series of 19 patients with NPM+/FLT3- autografted in first complete remission (CR) after conditioning with a regimen, named BuI, based on high-dose continuous infusion of idarubicin and Busulfan.	Idarubicin	222-232	nucleophosmin 1	Homo sapiens	78-81